Founded with a mission to revolutionize cardiac care, DRSLINQ focuses on developing innovative mobile EKG devices integrated with AI technology. Their core product is a mobile EKG device paired with an interactive application that uses natural language processing and machine learning to triage chest pain patients effectively. This solution aims to facilitate chronic heart disease management and provide immediate triage during episodes of chest discomfort, addressing the leading cause of death worldwide.

DRSLINQ has attracted attention from notable figures in the medical and tech industries, although specific names are not disclosed. The company has achieved significant milestones, including the development of a functional prototype and successful initial trials. Their impact lies in potentially reducing emergency room visits and improving outcomes for heart disease patients through timely and accurate triage, thereby transforming the landscape of virtual cardiology.